APO Research
Talk to an analyst

APO RESEARCH · REPORT

Stem Cell Therapy

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

Selected research

Market Structure

Global Stem Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025182 pages

Choose your research edition.

Industry ResearchStem Cell Therapy Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Stem Cell Therapy Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Stem Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Stem Cell Therapy Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Stem Cell Therapy Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.

North America is the largest Stem Cell Therapy market with about 65% market share. Europe is follower, accounting for about 16% market share.

The key players are Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, JCR Pharmaceutical, Pharmicell, Medi-post, Anterogen, Molmed, Takeda (TiGenix) etc. Top 3 companies occupied about 38% market share.

Read the full market overview

Report Includes

This report provides an overview of the global Stem Cell Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Stem Cell Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Stem Cell Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Stem Cell Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Stem Cell Therapy Segment by Company

Osiris Therapeutics

NuVasive

Chiesi Pharmaceuticals

JCR Pharmaceutical

Pharmicell

Medi-post

Anterogen

Molmed

Takeda (TiGenix)

Stem Cell Therapy Segment by Type

Autologous

Allogeneic

Stem Cell Therapy Segment by Application

Musculoskeletal Disorder

Wounds & Injuries

Cornea

Cardiovascular Diseases

Others

Stem Cell Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Stem Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Stem Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Stem Cell Therapy industry.

Chapter 3: Detailed analysis of Stem Cell Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Stem Cell Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Autologous Table 3. Key Players of Allogeneic Table 4. Global Stem Cell Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Musculoskeletal Disorder Table 6. Key Players of Wounds & Injuries Table 7. Key Players of Cornea Table 8. Key Players of Cardiovascular Diseases Table 9. Key Players of Others Table 10. Global Stem Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Stem Cell Therapy Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Stem Cell Therapy Market Share by Region (2021-2026) Table 13. Global Stem Cell Therapy Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Stem Cell Therapy Market Share by Region (2027-2032) Table 15. Stem Cell Therapy Industry Trends Table 16. Stem Cell Therapy Industry Drivers Table 17. Stem Cell Therapy Industry Opportunities and Challenges Table 18. Stem Cell Therapy Industry Restraints Table 19. Global Stem Cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Stem Cell Therapy Revenue Market Share by Company (2021-2026) Table 21. Global Stem Cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Stem Cell Therapy Key Company Head Office and Area Served Table 23. Global Stem Cell Therapy Company, Product Type & Application Table 24. Global Stem Cell Therapy Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Stem Cell Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Stem Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Stem Cell Therapy Revenue Market Share by Type (2021-2026) Table 31. Global Stem Cell Therapy Revenue Market Share by Type (2027-2032) Table 32. Global Stem Cell Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Stem Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Stem Cell Therapy Revenue Market Share by Application (2021-2026) Table 36. Global Stem Cell Therapy Revenue Market Share by Application (2027-2032) Table 37. Osiris Therapeutics Company Information Table 38. Osiris Therapeutics Business Overview Table 39. Osiris Therapeutics Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Osiris Therapeutics Stem Cell Therapy Product Portfolio Table 41. Osiris Therapeutics Recent Development Table 42. NuVasive Company Information Table 43. NuVasive Business Overview Table 44. NuVasive Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. NuVasive Stem Cell Therapy Product Portfolio Table 46. NuVasive Recent Development Table 47. Chiesi Pharmaceuticals Company Information Table 48. Chiesi Pharmaceuticals Business Overview Table 49. Chiesi Pharmaceuticals Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Chiesi Pharmaceuticals Stem Cell Therapy Product Portfolio Table 51. Chiesi Pharmaceuticals Recent Development Table 52. JCR Pharmaceutical Company Information Table 53. JCR Pharmaceutical Business Overview Table 54. JCR Pharmaceutical Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. JCR Pharmaceutical Stem Cell Therapy Product Portfolio Table 56. JCR Pharmaceutical Recent Development Table 57. Pharmicell Company Information Table 58. Pharmicell Business Overview Table 59. Pharmicell Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Pharmicell Stem Cell Therapy Product Portfolio Table 61. Pharmicell Recent Development Table 62. Medi-post Company Information Table 63. Medi-post Business Overview Table 64. Medi-post Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Medi-post Stem Cell Therapy Product Portfolio Table 66. Medi-post Recent Development Table 67. Anterogen Company Information Table 68. Anterogen Business Overview Table 69. Anterogen Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Anterogen Stem Cell Therapy Product Portfolio Table 71. Anterogen Recent Development Table 72. Molmed Company Information Table 73. Molmed Business Overview Table 74. Molmed Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Molmed Stem Cell Therapy Product Portfolio Table 76. Molmed Recent Development Table 77. Takeda (TiGenix) Company Information Table 78. Takeda (TiGenix) Business Overview Table 79. Takeda (TiGenix) Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Takeda (TiGenix) Stem Cell Therapy Product Portfolio Table 81. Takeda (TiGenix) Recent Development Table 82. North America Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 83. North America Stem Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 84. North America Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 85. North America Stem Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 86. North America Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. North America Stem Cell Therapy Market Size by Country (2021-2026) Table 88. North America Stem Cell Therapy Market Size by Country (2027-2032) Table 89. Europe Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 90. Europe Stem Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 91. Europe Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 92. Europe Stem Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 93. Europe Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. Europe Stem Cell Therapy Market Size by Country (2021-2026) Table 95. Europe Stem Cell Therapy Market Size by Country (2027-2032) Table 96. China Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 97. China Stem Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 98. China Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 99. China Stem Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 100. Asia Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 101. Asia Stem Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 102. Asia Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 103. Asia Stem Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 104. Asia Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Asia Stem Cell Therapy Market Size by Country (2021-2026) Table 106. Asia Stem Cell Therapy Market Size by Country (2027-2032) Table 107. South America, Middle East & Africa Stem Cell Therapy Market Size by Type (2021-2026) & (US$ Million) Table 108. South America, Middle East & Africa Stem Cell Therapy Market Size by Type (2027-2032) & (US$ Million) Table 109. South America, Middle East & Africa Stem Cell Therapy Market Size by Application (2021-2026) & (US$ Million) Table 110. South America, Middle East & Africa Stem Cell Therapy Market Size by Application (2027-2032) & (US$ Million) Table 111. South America, Middle East & Africa Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. South America, Middle East & Africa Stem Cell Therapy Market Size by Country (2021-2026) Table 113. South America, Middle East & Africa Stem Cell Therapy Market Size by Country (2027-2032) Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Stem Cell Therapy Product Image Figure 2. Global Stem Cell Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Stem Cell Therapy Market Share by Type: 2025 VS 2032 Figure 4. Autologous Image Figure 5. Allogeneic Image Figure 6. Global Stem Cell Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Stem Cell Therapy Market Share by Application: 2025 VS 2032 Figure 8. Musculoskeletal Disorder Image Figure 9. Wounds & Injuries Image Figure 10. Cornea Image Figure 11. Cardiovascular Diseases Image Figure 12. Others Image Figure 13. Global Stem Cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 15. Global Stem Cell Therapy Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Stem Cell Therapy Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Stem Cell Therapy Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Stem Cell Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Stem Cell Therapy Revenue Market Share by Type (2021-2032) Figure 22. Global Stem Cell Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Stem Cell Therapy Revenue Market Share by Application (2021-2032) Figure 24. North America Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 25. North America Stem Cell Therapy Market Share by Type (2021-2032) Figure 26. North America Stem Cell Therapy Market Share by Application (2021-2032) Figure 27. North America Stem Cell Therapy Market Share by Country (2021-2032) Figure 28. United States Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Canada Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 31. Europe Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 32. Europe Stem Cell Therapy Market Share by Type (2021-2032) Figure 33. Europe Stem Cell Therapy Market Share by Application (2021-2032) Figure 34. Europe Stem Cell Therapy Market Share by Country (2021-2032) Figure 35. Germany Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 36. France Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 38. Italy Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 39. Russia Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 41. China Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 42. China Stem Cell Therapy Market Share by Type (2021-2032) Figure 43. China Stem Cell Therapy Market Share by Application (2021-2032) Figure 44. Asia Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 45. Asia Stem Cell Therapy Market Share by Type (2021-2032) Figure 46. Asia Stem Cell Therapy Market Share by Application (2021-2032) Figure 47. Asia Stem Cell Therapy Market Share by Country (2021-2032) Figure 48. Japan Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 52. India Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 53. Australia Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Stem Cell Therapy Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Stem Cell Therapy Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Stem Cell Therapy Market Share by Country (2021-2032) Figure 58. Brazil Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 63. UAE Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 65. Chile Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Autologous
  • Allogeneic
Applications
  • Musculoskeletal Disorder
  • Wounds & Injuries
  • Cornea
  • Cardiovascular Diseases
  • Others
Companies covered
  • Osiris Therapeutics
  • NuVasive
  • Chiesi Pharmaceuticals
  • JCR Pharmaceutical
  • Pharmicell
  • Medi-post
  • Anterogen
  • Molmed
  • Takeda (TiGenix)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Stem Cell Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Autologous
  5. 1.2.3 Allogeneic
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Stem Cell Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Musculoskeletal Disorder
  9. 1.3.3 Wounds & Injuries
  10. 1.3.4 Cornea
  11. 1.3.5 Cardiovascular Diseases
  12. 1.3.6 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Stem Cell Therapy Growth Trends by Region
  15. 1.5.1 Global Stem Cell Therapy Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Stem Cell Therapy Market Size by Region (2021-2026)
  17. 1.5.3 Stem Cell Therapy Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Stem Cell Therapy Market Dynamics
  1. 2.1 Stem Cell Therapy Industry Trends
  2. 2.2 Stem Cell Therapy Industry Drivers
  3. 2.3 Stem Cell Therapy Industry Opportunities and Challenges
  4. 2.4 Stem Cell Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Stem Cell Therapy Revenue by Company (2021-2026)
  2. 3.2 Global Stem Cell Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Stem Cell Therapy Key Company Head office and Area Served
  4. 3.4 Global Stem Cell Therapy Company, Product Type & Application
  5. 3.5 Global Stem Cell Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Stem Cell Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Stem Cell Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Stem Cell Therapy Tier 1, Tier 2, and Tier 3
4 Stem Cell Therapy Market by Type
  1. 4.1 Global Stem Cell Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Stem Cell Therapy Market Size by Type (2021-2032)
  3. 4.3 Global Stem Cell Therapy Market Size Share by Type (2021-2032)
5 Stem Cell Therapy Market by Application
  1. 5.1 Global Stem Cell Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Stem Cell Therapy Market Size by Application (2021-2032)
  3. 5.3 Global Stem Cell Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Osiris Therapeutics
  2. 6.1.1 Osiris Therapeutics Company Information
  3. 6.1.2 Osiris Therapeutics Business Overview
  4. 6.1.3 Osiris Therapeutics Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Osiris Therapeutics Stem Cell Therapy Product Portfolio
  6. 6.1.5 Osiris Therapeutics Recent Developments
  7. 6.2 NuVasive
  8. 6.2.1 NuVasive Company Information
  9. 6.2.2 NuVasive Business Overview
  10. 6.2.3 NuVasive Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 NuVasive Stem Cell Therapy Product Portfolio
  12. 6.2.5 NuVasive Recent Developments
  13. 6.3 Chiesi Pharmaceuticals
  14. 6.3.1 Chiesi Pharmaceuticals Company Information
  15. 6.3.2 Chiesi Pharmaceuticals Business Overview
  16. 6.3.3 Chiesi Pharmaceuticals Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Chiesi Pharmaceuticals Stem Cell Therapy Product Portfolio
  18. 6.3.5 Chiesi Pharmaceuticals Recent Developments
  19. 6.4 JCR Pharmaceutical
  20. 6.4.1 JCR Pharmaceutical Company Information
  21. 6.4.2 JCR Pharmaceutical Business Overview
  22. 6.4.3 JCR Pharmaceutical Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 JCR Pharmaceutical Stem Cell Therapy Product Portfolio
  24. 6.4.5 JCR Pharmaceutical Recent Developments
  25. 6.5 Pharmicell
  26. 6.5.1 Pharmicell Company Information
  27. 6.5.2 Pharmicell Business Overview
  28. 6.5.3 Pharmicell Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pharmicell Stem Cell Therapy Product Portfolio
  30. 6.5.5 Pharmicell Recent Developments
  31. 6.6 Medi-post
  32. 6.6.1 Medi-post Company Information
  33. 6.6.2 Medi-post Business Overview
  34. 6.6.3 Medi-post Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Medi-post Stem Cell Therapy Product Portfolio
  36. 6.6.5 Medi-post Recent Developments
  37. 6.7 Anterogen
  38. 6.7.1 Anterogen Company Information
  39. 6.7.2 Anterogen Business Overview
  40. 6.7.3 Anterogen Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Anterogen Stem Cell Therapy Product Portfolio
  42. 6.7.5 Anterogen Recent Developments
  43. 6.8 Molmed
  44. 6.8.1 Molmed Company Information
  45. 6.8.2 Molmed Business Overview
  46. 6.8.3 Molmed Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Molmed Stem Cell Therapy Product Portfolio
  48. 6.8.5 Molmed Recent Developments
  49. 6.9 Takeda (TiGenix)
  50. 6.9.1 Takeda (TiGenix) Company Information
  51. 6.9.2 Takeda (TiGenix) Business Overview
  52. 6.9.3 Takeda (TiGenix) Stem Cell Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Takeda (TiGenix) Stem Cell Therapy Product Portfolio
  54. 6.9.5 Takeda (TiGenix) Recent Developments
7 North America
  1. 7.1 North America Stem Cell Therapy Market Size (2021-2032)
  2. 7.2 North America Stem Cell Therapy Market Size by Type
  3. 7.2.1 North America Stem Cell Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Stem Cell Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Stem Cell Therapy Market Share by Type (2021-2032)
  6. 7.3 North America Stem Cell Therapy Market Size by Application
  7. 7.3.1 North America Stem Cell Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Stem Cell Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Stem Cell Therapy Market Share by Application (2021-2032)
  10. 7.4 North America Stem Cell Therapy Market Size by Country
  11. 7.4.1 North America Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Stem Cell Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Stem Cell Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Stem Cell Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Stem Cell Therapy Market Size (2021-2032)
  2. 8.2 Europe Stem Cell Therapy Market Size by Type
  3. 8.2.1 Europe Stem Cell Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Stem Cell Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Stem Cell Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe Stem Cell Therapy Market Size by Application
  7. 8.3.1 Europe Stem Cell Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Stem Cell Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Stem Cell Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe Stem Cell Therapy Market Size by Country
  11. 8.4.1 Europe Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Stem Cell Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Stem Cell Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Stem Cell Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Stem Cell Therapy Market Size (2021-2032)
  2. 9.2 China Stem Cell Therapy Market Size by Type
  3. 9.2.1 China Stem Cell Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China Stem Cell Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China Stem Cell Therapy Market Share by Type (2021-2032)
  6. 9.3 China Stem Cell Therapy Market Size by Application
  7. 9.3.1 China Stem Cell Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China Stem Cell Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China Stem Cell Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Stem Cell Therapy Market Size (2021-2032)
  2. 10.2 Asia Stem Cell Therapy Market Size by Type
  3. 10.2.1 Asia Stem Cell Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Stem Cell Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Stem Cell Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia Stem Cell Therapy Market Size by Application
  7. 10.3.1 Asia Stem Cell Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Stem Cell Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Stem Cell Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia Stem Cell Therapy Market Size by Country
  11. 10.4.1 Asia Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Stem Cell Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Stem Cell Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Stem Cell Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Stem Cell Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Stem Cell Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Stem Cell Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Stem Cell Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Stem Cell Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Stem Cell Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Stem Cell Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Stem Cell Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Stem Cell Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Stem Cell Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Stem Cell Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Stem Cell Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Stem Cell Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Stem Cell Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst